SCHEMBL18156763

SCHEMBL18156763

c1ccc(-n2c(-c3cccc4c3-c3ccccc3C43c4ccccc4-c4ccc5oc6ccccc6c5c43)nc3ccccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.40
RPS6KB1 P23443 5/20 0.38
GSK3B P49841 2/20 0.38
ROCK1 Q13464 2/20 0.38
PRKACA P17612 1/20 0.38
ESR1 P03372 3/20 0.35
ESR2 Q92731 3/20 0.35
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
RPS6KA5 O75582 1/20 0.31
GSR P00390 1/20 0.31
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18156758 0.93 ESR1 (0.38) RECQLRPS6KB1GSK3BROCK1PRKACA
SCHEMBL16855322 0.90 RECQL (0.42) RECQLRPS6KB1GSK3BROCK1PRKACA
SCHEMBL15593165 0.82 RECQL (0.53) RECQLRPS6KB1GSK3BROCK1PRKACA
SCHEMBL18156741 0.82 RECQL (0.41) RECQLRPS6KB1GSK3BROCK1PRKACA
SCHEMBL20224492 0.82 RECQL (0.36) RECQLRPS6KB1GSK3BROCK1PRKACA
SCHEMBL8783487 0.81 RECQL (0.54) RECQLRPS6KB1GSK3BROCK1PRKACA
SCHEMBL18156765 0.81 ESR1 (0.37) RECQLRPS6KB1GSK3BROCK1PRKACA
SCHEMBL18159578 0.79 RECQL (0.47) RECQLRPS6KB1GSK3BROCK1PRKACA
SCHEMBL18156734 0.79 RECQL (0.40) RECQLRPS6KB1GSK3BROCK1PRKACA
SCHEMBL19194342 0.79 ESR1 (0.36) RECQLRPS6KB1GSK3BROCK1PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-11545634-B2 Heterocyclic spiro compounds MERCK PATENT GMBH (DE) 2023-01-03 US disclosed
US-10777750-B2 Heterocyclic spiro compounds BASF SE (DE) 2020-09-15 US disclosed
US-20200266364-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2020-08-20 US disclosed
EP-3083880-B1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2020-04-01 EP disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 RECQL 1091/4885RPS6KB1 3033/4885GSK3B 3621/4885
US-11545634-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 RECQL 1091/4885RPS6KB1 3033/4885GSK3B 3621/4885
US-20200266364-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 RECQL 1091/4885RPS6KB1 3033/4885GSK3B 3621/4885
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 RECQL 1091/4885RPS6KB1 3033/4885GSK3B 3621/4885
US-10777750-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 RECQL 1091/4885RPS6KB1 3033/4885GSK3B 3621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.